| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 335 |
| 1 | METFORMIN | 59 |
| 2 | ARIPIPRAZOLE | 57 |
| 3 | AMISULPRIDE | 50 |
| 4 | LORAZEPAM | 49 |
| 5 | METFORMIN ER 500 MG | 49 |
| 6 | METFORMIN ER 750 MG | 49 |
| 7 | QUETIAPINE | 45 |
| 8 | OLANZAPINE | 41 |
| 9 | QUETIAPINE EXTENDED-RELEASE | 37 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADENINE | 2 | 0.0556 |
| 1 | AMISULPRIDE | 50 | 0.0110 |
| 2 | CLOZAPINE | 335 | 0.0034 |
| 3 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 7 | 0.0029 |
| 4 | BENZTROPINE | 12 | 0.0020 |
| 5 | HALOPERIDOL DECANOATE | 4 | 0.0018 |
| 6 | SODIUM FLUORIDE F18 | 1 | 0.0018 |
| 7 | TOOTHPASTE | 1 | 0.0018 |
| 8 | SODIUM FLUORIDE F-18 | 1 | 0.0018 |
| 9 | LITHIUM | 28 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 381 |
| 1 | Benzodiazepine [EPC] | 92 |
| 2 | Mood Stabilizer [EPC] | 61 |
| 3 | Anti-epileptic Agent [EPC] | 60 |
| 4 | Proton Pump Inhibitor [EPC] | 51 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 50 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 37 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 21 |
| 8 | Loop Diuretic [EPC] | 14 |
| 9 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 50 | 0.0087 |
| 1 | Atypical Antipsychotic [EPC] | 381 | 0.0009 |
| 2 | Anticholinergic [EPC] | 9 | 0.0007 |
| 3 | Typical Antipsychotic [EPC] | 9 | 0.0004 |
| 4 | Tetracycline-class Antibacterial [EPC] | 2 | 0.0004 |
| 5 | Antimycobacterial [EPC] | 6 | 0.0004 |
| 6 | Cholinergic Muscarinic Antagonist [EPC] | 12 | 0.0004 |
| 7 | Mood Stabilizer [EPC] | 61 | 0.0003 |
| 8 | Anti-epileptic Agent [EPC] | 60 | 0.0003 |
| 9 | Alkaloid [EPC] | 7 | 0.0003 |